PHIPing along: Evolution of PHIP as a cancer biomarker and a target for therapy
Oncotarget
.
2018 Nov 16;9(90):36055-36056.
doi: 10.18632/oncotarget.26341.
Authors
Mohammed Kashani-Sabet
1
,
Vladimir Bezrookove
1
,
David de Semir
1
Affiliation
1
Center for Melanoma Research and Treatment, California Pacific Medical Center (CPMC) Research Institute, San Francisco, CA, USA.
PMID:
30546826
PMCID:
PMC6281419
DOI:
10.18632/oncotarget.26341
No abstract available
Keywords:
PHIP; cancer biomarker; melanoma; targeted therapy.
Publication types
Editorial
Grants and funding
R01 CA175768/CA/NCI NIH HHS/United States
R01 CA215755/CA/NCI NIH HHS/United States